Immune-Associated Gene Signatures Serve as a Promising Biomarker of Immunotherapeutic Prognosis for Renal Clear Cell Carcinoma

Immune-Associated Gene Signatures Serve as a Promising Biomarker of Immunotherapeutic Prognosis for Renal Clear Cell Carcinoma

As the most common type of renal cell carcinoma (RCC), the renal clear cell carcinoma (ccRCC) is highly malignant and insensitive to chemotherapy or radiotherapy. Although systemic immunotherapies have been successfully applied to ccRCC in recent years, screening for patients who can benefit most fr...

Full description

Bibliographic Details
Main Authors: Qi Wang, Hanmin Tang, Xuehui Luo, Jie Chen, Xinyue Zhang, Xinyue Li, Yuesen Li, Yuetong Chen, Yungang Xu, Suxia Han
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Immunology
Subjects:
renal clear cell carcinoma (ccRCC)
immune checkpoint inhibition
IRPDGs
tumor microenvironment
prognostic biomarker
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.890150/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.890150/full

Similar Items